Drug delivery system. Enzyme supplementation therapy for genetic enzyme deficiencies.
نویسندگان
چکیده
منابع مشابه
Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
Peptide dendrimers have shown promise as an attractive platform for drug delivery. In this study, mPEGylated peptide dendrimer-doxorubicin (dendrimer-DOX) conjugate-based nanoparticle is prepared and characterized as an enzyme-responsive drug delivery vehicle. The drug DOX is conjugated to the periphery of dendrimer via an enzyme-responsive tetra-peptide linker Gly-Phe-Leu-Gly (GFLG). The dendr...
متن کاملPhytosome: Drug Delivery System for Polyphenolic Phytoconstituents
Several plant extracts and phytoconstituents, despite having excellent bioactivity in vitro, demonstrate less or no in vivo actions due to their poor lipid solubility or improper molecular size or destruction in gut. Drug delivery system for polyphenolic phytoconstituents (phytosomes) was prepared by complexing polyphenolic phytoconstituents with phospholipid mainly phosphatidylcholine wh...
متن کاملEnzyme Therapy in Genetic Diseases: 2
forming and coagulation proteins, and (vi) immunoassays for complement components. Each of the six sections contains four papers, which are well-organized and comprehensive, having an outline of their contents on the title page and often including.discussions of materials, methods, apparatus, and potential limitations in addition to the principles behind the technique in question. Throughout th...
متن کاملEnzyme Therapy in Genetic Diseases 2
chromosomes, and the sections are divided into structural variations and anomalies, numerical variations and anomalies, double aneuploidies, chromosome breakage syndromes, and a small list of mapping data of loci assigned to chromosomes. A short appendix outlines the clinical features of the major autosomal and sex chromosome abnormalities. This book is a veritable gold mine of information abou...
متن کاملTargeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers.
The development of novel therapeutic strategies allowing the destruction of tumour cells while sparing healthy tissues is one of the main challenges of cancer chemotherapy. Here, we report on the design and antitumour activity of a low-molecular-weight drug delivery system programmed for the selective release of the potent monomethylauristatin E in the tumour microenvironment of solid tumours. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Delivery System
سال: 1989
ISSN: 1881-2732,0913-5006
DOI: 10.2745/dds.4.243